The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Keith W. Muir

Institute of Neurological Sciences

Southern General Hospital

Glasgow G51 4TF

UK

[email]@clinmed.gla.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK. 1998 - 2008
  • Division of Clinical Neurosciences, University of Glasgow, Southern General Hospital, 1345 Govan Road, UK. 2006 - 2007
  • Acute Stroke Unit, University Department of Medicine, Department of Immunology, Glasgow, Scotland. 1999 - 2000

References

  1. The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism. Muir, K.W. Stroke (2008) [Pubmed]
  2. Inflammation and ischaemic stroke. Muir, K.W., Tyrrell, P., Sattar, N., Warburton, E. Curr. Opin. Neurol. (2007) [Pubmed]
  3. Can the ischemic penumbra be identified on noncontrast CT of acute stroke?. Muir, K.W., Baird-Gunning, J., Walker, L., Baird, T., McCormick, M., Coutts, S.B. Stroke (2007) [Pubmed]
  4. Visual evaluation of perfusion computed tomography in acute stroke accurately estimates infarct volume and tissue viability. Muir, K.W., Halbert, H.M., Baird, T.A., McCormick, M., Teasdale, E. J. Neurol. Neurosurg. Psychiatr. (2006) [Pubmed]
  5. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Muir, K.W. Curr. Opin. Pharmacol (2006) [Pubmed]
  6. Imaging of acute stroke and transient ischaemic attack. Muir, K.W., Santosh, C. J. Neurol. Neurosurg. Psychiatr. (2005) [Pubmed]
  7. Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design. Muir, K.W. Stroke (2002) [Pubmed]
  8. Magnesium in stroke treatment. Muir, K.W. Postgrad. Med. J (2002) [Pubmed]
  9. Medical management of stroke. Muir, K.W. J. Neurol. Neurosurg. Psychiatr. (2001) [Pubmed]
  10. Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. Muir, K.W. CNS. Drugs (2001) [Pubmed]
  11. Thrombolytic therapy for stroke: a review with particular reference to elderly patients. Muir, K.W., Roberts, M. Drugs. Aging (2000) [Pubmed]
  12. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Muir, K.W., Watt, A., Baxter, G., Grosset, D.G., Lees, K.R. QJM (2000) [Pubmed]
  13. Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke. Muir, K.W., Holzapfel, L., Lees, K.R. Cerebrovasc. Dis. (2000) [Pubmed]
  14. C-reactive protein and outcome after ischemic stroke. Muir, K.W., Weir, C.J., Alwan, W., Squire, I.B., Lees, K.R. Stroke (1999) [Pubmed]
  15. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Muir, K.W. Magnes. Res (1998) [Pubmed]
 
WikiGenes - Universities